P
Profusa, Inc. (PFSA)
NCM – Real vaqt narxi. Valyuta: USD
0.97
-0.01 (-1.53%)
Bozor ochiq: Aug 12, 2026, 2:43 PM EDT
0.96
-0.03 (-2.74%)
Oldingi bozordan keyin: Aug 11, 2026, 7:47 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.97
-0.01 (-1.53%)
Bozor ochiq: Aug 12, 2026, 2:43 PM EDT
0.96
-0.03 (-2.74%)
Oldingi bozordan keyin: Aug 11, 2026, 7:47 PM EDT
Profusa, Inc., raqamli sog'liqni saqlash texnologiyalari kompaniyasi, AQShda shaxsiy va tibbiy maqsadlarda klinik darajadagi ma'lumotlarni aniqlash va uzluksiz uzatish uchun mo'ljallangan biomuhandislik sensorlarini ishlab chiqadi. Kompaniya periferik arteriya kasalliklari, surunkali yaralar va rekonstruktiv jarrohlik natijasida to'qimalarning buzilishini kuzatish uchun Lumee Oxygen Platformasini taklif etadi. Kompaniya Lumee Glucose Platformasini tadqiq qiladi va ishlab chiqadi, u interstitsial suyuqlikdagi glyukoza darajasini kuzatish uchun mo'ljallangan. Profusa, Inc. Berklida, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Chung-Bin Hwang Ph.D. | President |
| Mr. David Icke | Head of Digital Health Business |
| Mr. Fred S. Knechtel | Chief Financial Officer |
| Mr. Jack E. Stover CPA | CEO & Executive Chairman |
| Mr. Sean Givens | Head of Government Business |
| Mr. William McMillan | Co-founder, Chief Scientific Officer & Head of Research |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-31 | 8-K | ea0300017-8k_profusa.htm |
| 2026-07-27 | 8-K | ea0298832-8k_profusa.htm |
| 2026-07-06 | 8-K | ea0297130-8k_profusa.htm |
| 2026-06-23 | 8-K | ea0295656-8k_profusa.htm |
| 2026-06-08 | 8-K | ea0293894-8k_profusa.htm |
| 2026-05-26 | DEF 14A | ea0289795-02.htm |
| 2026-05-26 | ARS | ea0289795-04.pdf |
| 2026-05-26 | 8-K | ea0292151-8k_profusa.htm |
| 2026-05-18 | 8-K | ea0291342-8k_profusa.htm |
| 2026-05-15 | 8-K | ea0291023-8k_profusa.htm |